3-methoxytyrosine has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carey, RJ | 1 |
| Dai, H | 1 |
| Huston, JP | 1 |
| Pinheiro-Carrera, M | 1 |
| Schwarting, RK | 1 |
| Tomaz, C | 1 |
| Fujitake, J | 1 |
| Kuno, S | 1 |
| Mizuta, E | 1 |
2 other studies available for 3-methoxytyrosine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
L-DOPA metabolism in cortical and striatal tissues in an animal model of parkinsonism.
Topics: Animals; Dopamine; Levodopa; Male; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Prefronta | 1995 |
Interference of 3-O-methyldopa with L-dopa treatment for MPTP-induced parkinsonism in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Injections, Intrav | 1990 |